2 results match your criteria: "Inner Mongolia Chifeng Hospital[Affiliation]"
Kaohsiung J Med Sci
January 2019
Department of Medical Oncology in Section One, Inner Mongolia Chifeng Hospital, Chifeng, China.
J Cell Biochem
January 2018
Department of Medical Oncology in Section One, Inner Mongolia Chifeng Hospital, Chifeng, P. R. China.
The mammalian target of rapamycin (mTOR) pathway is dysregulated in more than 50% of all human malignancies and is a major target in cancer treatment. In this study, we explored the underlying mechanism involving microRNA-145-3p (miR-145-3p) in the development and progression of non-small cell lung cancer (NSCLC) by targeting PDK1 via the mTOR signaling pathway. NSCLC tissues and adjacent normal tissues were obtained from 83 NSCLC patients.
View Article and Find Full Text PDF